Important Information and Top Tips!
For maximum functionality please use Google Chrome or Firefox.
IDWeek Regular Deadline and Late Breaker Abstracts are embargoed until October 16 at 12:01 a.m. PT.
Users must be logged in to access Abstract Content.
Date & Time |
MedTalk | Description and Presenter(s) |
Thursday, Oct. 17, 10-10:30 a.m. | Mystery Case Conference | Please join us for a Fellows case conference hosted by IDSA and the IDSA Fellows Community of Practice. All are welcome to join us for an interesting case presentation and group discussion, presented by Dr. William Z. Webster of UNC Rex and featuring Dr. Daniel Minter of UCSF as our faculty discussant. Speakers: William Z. Webster, DO; UNC Health Rex Daniel Minter, MD; University of California, San Francisco |
Friday, Oct. 18, 10-10:30 a.m. | Next Gen Advocacy: How to Become an Advocacy Leader | Hear from IDSA and HIVMA advocacy staff and member advocates on how to make your voice heard on Capitol Hill to advance ID and HIV policy priorities, including strengthening ID/HIV compensation and building the next generation of ID/HIV professionals. Speakers: Bismarck Bisono Garcia, MD; Mayo Clinic, Rabita Aziz, MPH; IDSA Associate Director of Advocacy Jose Rodriguez; HIVMA Associate Director of Advocacy and Policy |
Saturday, Oct 19, 2-2:30 p.m. | Meet the IDSA Editors | Q&A with the IDSA journal editors-in-chief, exclusively for medical students, residents, and ID fellows. Speakers: Roger Bedimo, MD, Editor-in-Chief, Open Forum Infectious Diseases; Chief of Infectious Diseases Section, VA North Texas Health Care System; Professor of Medicine, University of Texas Southwestern Medical Center Paul Sax, MD, Editor-in-Chief, Clinical Infectious Diseases; Clinical Director of the Division of Infectious Diseases, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School Cynthia Sears, MD, Editor-in-Chief, The Journal of Infectious Diseases; Professor of Medicine, Oncology, and Molecular Microbiology and Immunology, Johns Hopkins University School of Medicine and Bloomberg School of Public Health; Microbiome Program Leader, Bloomberg~Kimmel Institute for Cancer Immunotherapy |